Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Low dose aspirin dosages trigger the body to generate its own anti-inflammatory compounds

Researchers at Brigham and Women’s Hospital (BWH) and colleagues have demonstrated for the first time in humans in a randomized clinical trial that low-dose aspirin - dosages equivalent to one baby aspirin (81 mg) - trigger the body to generate its own anti-inflammatory compounds that help fight unwanted inflammation.

13 Oct 2004

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

An estimated 42 percent of Americans use herbal medicines or nutritional supplements. Many people taking these products and their physicians are unaware of the adverse reactions they can cause.

13 Oct 2004

Researchers have discovered an effective new way to treat giant cell arteritis

Mayo Clinic researchers have discovered an effective new way to treat giant cell arteritis (GCA), a debilitating cause of headaches, fatigue, muscle pain and even blindness. The findings of this research will be presented at the American College of Rheumatology Annual Scientific Meeting.

13 Oct 2004

New survey reveals continued drug price disparities across the New York State

New York State Attorney General Eliot Spitzer has announced that his office's drug price website has been expanded to include pharmacies within every county in New York State.

11 Oct 2004

Signaling pathway could be a valuable target for future drug therapies against systemic lupus erythematosus

Medical investigators at the Hospital for Special Surgery have identified an important new signaling pathway they believe could be a valuable target for scientists to aim at with future drug therapies that might one day reverse diseases such as systemic lupus erythematosus, according to a recent article published in “Nature Immunology.”

11 Oct 2004

Atheromatosis, which lies behind heart attacks, stroke, and other cardiovascular problems, has a major impact on public health

These two diseases are completely different from each other, but they do have one common denominator: inflammation. Researchers at Lund University in Sweden can now show that it might also be possible to treat them with the same drug.

10 Oct 2004

Shortage of pediatric rheumatologists often leads to improper diagnosis and treatment

More than 150,000 children in the United States are affected by rheumatic diseases such as juvenile rheumatoid arthritis, lupus, dermatomyositis, scleroderma, and systemic vasculitis.

10 Oct 2004

Aspirin might well be considered the top utility player in the medicine cabinet

This cheap over-the-counter drug can be used not only for fever, pain and arthritis, but to prevent heart attack, stroke or angina. It also may reduce the risk of colorectal cancer. Yet aspirin also has side effects worth considering, and its very accessibility may hamper its use.

8 Oct 2004

Canadian Rheumatology Association issues statement on Vioxx alternatives

The Canadian Rheumatology Association (CRA) has issued a statement to its 350 members and other interested parties, recommending alternative treatment considerations in the wake of the worldwide recall of Merck's rofecoxib, (Vioxx(R)) last week.

7 Oct 2004

Rheumatoid arthritis results from a combination of genetic susceptibility and environmental triggers

Rheumatoid arthritis (RA), like many chronic diseases of the immune system, likely results from a combination of genetic susceptibility and environmental triggers.

7 Oct 2004

Study underscores the need for improved prevention and treatment of torn knee ligaments among young female athletes

Of the more than 17 million players participating in organized soccer nationwide, 7 million are female. While offering an equal opportunity playing field for student athletes, soccer has one unfortunate gender bias: women are more susceptible to knee injury.

7 Oct 2004

18 percent of seniors with chronic conditions such as heart disease and depression skip medicines due to costs

A recent nationally representative survey of older adults finds that 18 percent of those with chronic conditions such as heart disease and depression skip some of their prescription medicines because of out-of-pocket cost pressures, and 14 percent do so at least every month.

6 Oct 2004

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.

4 Oct 2004

First U.S. program to allow citizens to purchase lower cost, safe prescription drugs from Europe and Canada

Illinois Gov. Rod R. Blagojevich and Congressman Rahm Emanuel (D-Chicago) were joined in Chicago today by Wisconsin Governor Jim Doyle to launch the new I-SaveRx prescription drug importation program -- the first program in the nation to allow citizens to purchase lower cost, safe prescription drugs from Europe and Canada.

4 Oct 2004

MHRA advice following withdrawal of Vioxx (rofecoxib)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued advice following the withdrawal of a widely-used pain-killer and anti-inflammatory drug Vioxx (rofecoxib).

4 Oct 2004

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Pfizer has said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to completion.

4 Oct 2004

We could soon be curing our athlete’s foot with alfalfa

We could be soon be curing our athlete’s foot with a common type of cattle feed, according to research reported today at the British Pharmaceutical Conference.

29 Sep 2004

Study to test the effectiveness of anti-depressants in treating symptoms of Parkinson’s disease

While Parkinson’s disease typically brings to mind symptoms such as tremors and slow movement, researchers have found that nearly half of all Parkinson’s patients also suffer from depression. While it might seem natural that someone who has a disease such as Parkinson’s might become depressed, it’s not so simple, says neurologist Irene Richard, M.D., who leads the study.

27 Sep 2004

Study on the long-term health effects associated with silicone breast implants

It is estimated that between 1.5 million and 2 million women in this country have had breast implants since they first appeared on the market in 1962.

23 Sep 2004

FDA proposed new egg safety regulations to reduce Salmonella Enteritidis cases

When implemented, the production changes defined by the regulation will significantly reduce the number of illness caused by eggs contaminated with Salmonella Enteritidis.

20 Sep 2004

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Low dose aspirin dosages trigger the body to generate its own anti-inflammatory compounds

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

Researchers have discovered an effective new way to treat giant cell arteritis

New survey reveals continued drug price disparities across the New York State

Signaling pathway could be a valuable target for future drug therapies against systemic lupus erythematosus

Atheromatosis, which lies behind heart attacks, stroke, and other cardiovascular problems, has a major impact on public health

Shortage of pediatric rheumatologists often leads to improper diagnosis and treatment

Aspirin might well be considered the top utility player in the medicine cabinet

Canadian Rheumatology Association issues statement on Vioxx alternatives

Rheumatoid arthritis results from a combination of genetic susceptibility and environmental triggers

Study underscores the need for improved prevention and treatment of torn knee ligaments among young female athletes

18 percent of seniors with chronic conditions such as heart disease and depression skip medicines due to costs

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

First U.S. program to allow citizens to purchase lower cost, safe prescription drugs from Europe and Canada

MHRA advice following withdrawal of Vioxx (rofecoxib)

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

We could soon be curing our athlete’s foot with alfalfa

Study to test the effectiveness of anti-depressants in treating symptoms of Parkinson’s disease

Study on the long-term health effects associated with silicone breast implants

FDA proposed new egg safety regulations to reduce Salmonella Enteritidis cases

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in